3,025
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma

, , , , , , & show all
Article: e1601478 | Received 24 Oct 2018, Accepted 22 Mar 2019, Published online: 17 Apr 2019

Figures & data

Figure 1. CD163 was significantly enriched in glioblastoma and in IDH wild-type glioma. (a, b, c) CD163 was highly expressed in glioblastoma (WHO IV) at transcription level. (d, e, f) CD163 was significantly up-regulated in IDH wild-type glioma. *** and **** represent p< 0.001 and p< 0.0001, respectively.

Figure 1. CD163 was significantly enriched in glioblastoma and in IDH wild-type glioma. (a, b, c) CD163 was highly expressed in glioblastoma (WHO IV) at transcription level. (d, e, f) CD163 was significantly up-regulated in IDH wild-type glioma. *** and **** represent p< 0.001 and p< 0.0001, respectively.

Figure 2. CD163 showed a strong expression pattern in mesenchymal molecular subtype glioma. (a, b, c) CD163 was highly enriched in mesenchymal molecular subtype glioma. (d, e, f) CD163 could serve as a biomarker to predict mesenchymal molecular subtype glioma. *, **, and **** represent p < 0.05, p< 0.01, and p< 0.0001, respectively.

Figure 2. CD163 showed a strong expression pattern in mesenchymal molecular subtype glioma. (a, b, c) CD163 was highly enriched in mesenchymal molecular subtype glioma. (d, e, f) CD163 could serve as a biomarker to predict mesenchymal molecular subtype glioma. *, **, and **** represent p < 0.05, p< 0.01, and p< 0.0001, respectively.

Figure 3. CD163 related immune genes and Gene Ontology (GO) terms in glioma. (a, b) CD163 showed a strong positive correlation with most of the immune genes related to GO terms especially in immune response, antigen process presentation, and angiogenesis.

Figure 3. CD163 related immune genes and Gene Ontology (GO) terms in glioma. (a, b) CD163 showed a strong positive correlation with most of the immune genes related to GO terms especially in immune response, antigen process presentation, and angiogenesis.

Figure 4. CD163 was tightly associated with immune score and infiltrated cells in tumor microenvironment. (a and b, upper panel) CD163 was positively related with immune score and stromal score. (a and b, lower panel) CD163 was closely related to infiltrated cells in tumor microenvironment.

Figure 4. CD163 was tightly associated with immune score and infiltrated cells in tumor microenvironment. (a and b, upper panel) CD163 was positively related with immune score and stromal score. (a and b, lower panel) CD163 was closely related to infiltrated cells in tumor microenvironment.

Figure 5. CD163-related inflammatory activities in CGGA database. (a) The heatmap of CD163 related inflammatory metagenes in CGGA cohort. (b) Corrgram of CD163 and inflammatory metagenes in CGGA cohort.

Figure 5. CD163-related inflammatory activities in CGGA database. (a) The heatmap of CD163 related inflammatory metagenes in CGGA cohort. (b) Corrgram of CD163 and inflammatory metagenes in CGGA cohort.

Figure 6. Survival analysis of CD163 in glioma and glioblastoma. (a, b, and c) Survival analysis of CD163 in whole grade glioma. (d, e, and f) Survival analysis of CD163 in glioblastoma.

Figure 6. Survival analysis of CD163 in glioma and glioblastoma. (a, b, and c) Survival analysis of CD163 in whole grade glioma. (d, e, and f) Survival analysis of CD163 in glioblastoma.
Supplemental material

Supplemental Material

Download Zip (3 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.